TY - JOUR
T1 - Allergen immunotherapy for IgE-mediated food allergy
T2 - Protocol for a systematic review
AU - Dhami, Sangeeta
AU - Nurmatov, Ulugbek
AU - Pajno, Giovanni Battista
AU - Fernandez-Rivas, Montserrat
AU - Muraro, Antonella
AU - Roberts, Graham
AU - Akdis, Cezmi
AU - Alvaro-Lozano, Montserrat
AU - Beyer, Kirsten
AU - Bindslev-Jensen, Carsten
AU - Burks, Wesley
AU - Du Toit, George
AU - Ebisawa, Motohiro
AU - Eigenmann, Philippe
AU - Knol, Edward
AU - Makela, Mika
AU - Nadeau, Kari Christine
AU - O'Mahony, Liam
AU - Papadopoulos, Nikolaos
AU - Poulsen, Lars
AU - Sackesen, Cansin
AU - Sampson, Hugh
AU - Santos, Alexandra
AU - Van Ree, Ronald
AU - Timmermans, Frans
AU - Sheikh, Aziz
N1 - Publisher Copyright:
© 2016 Dhami et al.
PY - 2016/7/5
Y1 - 2016/7/5
N2 - Background: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for IgE-mediated food allergy. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in IgE-mediated food allergy. Methods: We will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre-defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised. Discussion: The findings from this review will be used to inform the development of recommendations for EAACI's Guidelines on AIT.
AB - Background: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for IgE-mediated food allergy. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in IgE-mediated food allergy. Methods: We will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre-defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised. Discussion: The findings from this review will be used to inform the development of recommendations for EAACI's Guidelines on AIT.
KW - Allergen immunotherapy
KW - Allergy
KW - Food allergy
KW - Sensitisation
KW - Therapy
UR - https://www.scopus.com/pages/publications/85006305724
U2 - 10.1186/s13601-016-0113-z
DO - 10.1186/s13601-016-0113-z
M3 - Review article
AN - SCOPUS:85006305724
SN - 2045-7022
VL - 6
JO - Clinical and Translational Allergy
JF - Clinical and Translational Allergy
IS - 1
M1 - 24
ER -